Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05058846 · ClinicalTrials.gov registry record

Pilot Study of Pancreatic Cancer Screening

A clinical trial of Pancreatic Carcinoma, sponsored by University of California, San Francisco.

Recruiting
Registry status
250
Enrollment target
1
Study location

NCT05058846 is a study of Pancreatic Carcinoma that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 250 participants, below the 3,471-participant average among 18 other Pancreatic Carcinoma trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05058846, a study of Pancreatic Carcinoma, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
250 participants
Enrollment target
1
Study location

Study Summary

This study investigates how often abnormal findings from routine magnetic resonance imaging occur in people with genetic mutations in BReast CAncer gene. (BRCA), ataxia telangiectasia mutated gene (ATM), or PALB2 screened for pancreatic cancer. This study may lead to a greater understanding of cancer and potentially, improvements in cancer screening and treatment.

Conditions Studied

Pancreatic Carcinoma

Interventions

  • PROCEDURE Biospecimen Collection
  • PROCEDURE Magnetic Resonance Imaging
  • OTHER Questionnaires
  • PROCEDURE Magnetic Resonance Cholangiopancreatography
  • PROCEDURE Endoscopic ultrasound

Study Locations (1)

California

  • University of California San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2022-01-20
Est. Completion 2032-01-31

Sponsor

University of California, San Francisco

1,713 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05058846

The ClinicalTrials.gov registry entry for NCT05058846 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,471-participant average among 18 other Pancreatic Carcinoma trials with a reported enrollment target (93% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pancreatic Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Biospecimen Collection is the first listed.

NCT05058846 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05058846 about?

NCT05058846 is a clinical study titled "Pilot Study of Pancreatic Cancer Screening". This study investigates how often abnormal findings from routine magnetic resonance imaging occur in people with genetic mutations in BReast CAncer gene. (BRCA), ataxia telangiectasia mutated gene (ATM), or PALB2 screened for pancreatic cancer. This study may lead to a greater understanding of cance...

What is the current status of trial NCT05058846?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2022-01-20. Estimated completion is 2032-01-31.

What conditions does trial NCT05058846 study?

This clinical trial studies the following conditions: Pancreatic Carcinoma.

What interventions are being tested in trial NCT05058846?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Magnetic Resonance Imaging (PROCEDURE), Questionnaires (OTHER), Magnetic Resonance Cholangiopancreatography (PROCEDURE), Endoscopic ultrasound (PROCEDURE).

Who is sponsoring clinical trial NCT05058846?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05058846 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pancreatic Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pancreatic Carcinoma

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.